Terizidone
- Generic Name
- Terizidone
- Drug Type
- Small Molecule
- Chemical Formula
- C14H14N4O4
- CAS Number
- 25683-71-0
- Unique Ingredient Identifier
- 1199LEX5N8
- Background
Terizidone has been used in trials studying the treatment of Tuberculosis, HIV Infections, Multidrug Resistant Tuberculosis, and Extensively-drug Resistant Tuberculosis.
An Open-label RCT to Evaluate a New Treatment Regimen for Patients With Multi-drug Resistant Tuberculosis
Phase 2
Completed
- Conditions
- TuberculosisMultidrug Resistant TuberculosisExtensively-drug Resistant Tuberculosis
- Interventions
- First Posted Date
- 2015-05-27
- Last Posted Date
- 2021-09-29
- Lead Sponsor
- University of Cape Town
- Target Recruit Count
- 154
- Registration Number
- NCT02454205
- Locations
- 🇿🇦
Brooklyn Chest Hospital, Cape Town, Western Cape, South Africa
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath